Navigation Links
2009 Marks 50 Years of Innovative 'Firsts' for Instrumentation Laboratory
Date:1/12/2009

standards in diagnostic testing."

Ramon Benet, VP of Worldwide Marketing and US Sales and Service at IL, added, "The '50 and Forward' program not only celebrates our history, but embodies our commitment to the future of diagnostics - IL will continue to meet the changing needs of the in vitro diagnostic market, today and into the future."

Another IL "First" to be Introduced in Europe during Q1, 2009

As the world's leading developer of hemostasis testing systems, IL plans to begin 2009 with the launch of another innovative addition to its ACL family of hemostasis testing instruments, that use 'chemiluminescence' technology to automate specialty assays:

  • The highly-anticipated ACL AcuStar(TM), the first fully automated random-access chemiluminescence analyzer dedicated to specialty assays in hemostasis

"Passion and Results" Award Nominations for IL Customers Accepted thru June 1st.

The cornerstone of IL's 50th anniversary celebration is the "Passion and Results" Award for customers. Three laboratorians, respiratory therapists, physicians or nurses who have demonstrated remarkable passion and dedication resulting in enhanced patient care will receive an award and an educational grant to their institution. Industry professionals are invited to submit an inspiring story of patient care - about themselves or another person - by completing IL's "Passion and Results" nomination form available through an IL sales representative or online at www.ilus.com/50forward. Submissions will be accepted through June 1, 2009 and are open to all worldwide customers. Winners will be honored in July, 2009.

ILeader Panel of Experts Available to Industry.

IL's leadership in the development of diagnostic instruments is largely due to it
'/>"/>

SOURCE Instrumentation Laboratory
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. CPA Global Marks 40th Anniversary With Launch of New Brand
2. Ernst & Young Benchmarks Danish Biotech Pipeline Third in Europe
3. Pilot Study Finds Adding Topical Imiquimod To Laser Therapy Improves The Response Of Port Wine Stain Birthmarks
4. Fifth DuraHeart(TM) U.S. Implant Marks Important Milestone in U.S. Pivotal Trial
5. Expansion and Relocation to New, State-Of-The-Art Facilities Marks Milestone in Effort to Roll Out New Tool for Cancer Diagnosis
6. Developing Sales Leaders: Benchmarks Reveal Tactics that Will Propel Your Business
7. James Webb Space Telescope marks successful completion
8. Carl Marks Seeds New Healthcare Fund Through Strategic Partnership With BlueStar Capital Management
9. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
10. Social Network for Scientists Marks Ten Years Online
11. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)..., OMAHA, Neb., Nov. 5 T... announced financial results for the quarter ended...ts are presented in the tables that follow. ,, ...net loss of $366,000 or $0.01 per share for the th...499,000 or $0.01 per share for the third quarter o...
(Date:11/5/2009)..., FREMONT, Calif., Nov. 5 /PRNewswire-FirstCall/ ...WGBS), a leading developer of state-of-the-art gen...opher Sears, Ph.D. has joined the company,s Scient...on designing and commercializing novel molecular d...ions, and on the development of computational biol...
(Date:11/5/2009)... Brooke Sanders brings a new...ne, CA (PRWEB) November 5, 2009 -- Professional Re... reprographics company is pleased to present Brook... as their graphics/PR specialist. The addition of ...sistent growth within Professional Reprographics.,...
(Date:11/4/2009)..., ,, ROCKVILLE, Md., Nov. 4 /PRNewswire/ -... company focused on next-generation antibody drug ...10 million in Series A funding from New Enterprise...ure capital firms. The capital will be used to cre...that address two or more biological targets with a...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4
...y insiders knowingly misrepresented the .... 18 Hagens Berman Sobol Shapiro filed a,proposed...cs Corporation,(OTC Bulletin Board: CCYG) sharehol...esented the company and chief executive officer Ga...be traded at artificially,inflated prices., The l...
... and Company,strongly objects to implications in a...e company has suppressed results of negative clini...le in The New England Journal of,Medicine (NEJM), ... how the,industry purportedly suppresses negative ... inaccurate when it comes to Prozac -- the NEJM ar...
...utics Corporation today,announced the appointment ...Alliance Management. In this role, Ms. Perrow will...opment strategy and program execution through,prod...l also serve as a,member of Alba,s executive manag...nnounce that Ms. Perrow is joining Alba in,this cr...
Other Biology Technology:Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation 2Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation 3In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 2In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 3In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 4Alba Therapeutics Appoints Wendy Perrow as its Vice President, Marketing and Alliance Management 2
(Date:11/4/2009)...D, Calif., Oct. 23 GenVault Corpor... management for genomic discovery, medicine and id...h.D., GenVault,s President and CEO, will be presen...e on October 26th and 27th in La Jolla, CA. ,, ...n overview of the company together with recent cus...
(Date:11/4/2009)...K, Oct. 27 Global Rainmakers, Inc....anced R&D laboratory, today announced that the...ared to actively commercialize its suite of techno... security offerings. ,, During the past four ye...lars to develop and deploy a series of core--but e...
(Date:11/4/2009)...D, Calif., Nov. 4 GenVault Corpora...rody, M.D., Ph.D., has joined its Board of Directo...r of the Salk Institute, is an acclaimed physician...g the Salk Institute, Dr. Brody served as presiden... of the National Academy of Engineering and the In...
Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Martin Hensen head of e strategies UCB Germany 3A Making e marketing more than just an add on 9458 1Five Questions About Protopic 28tacrolimus 29 Ointment 13332 1Five Questions About Protopic 28tacrolimus 29 Ointment 13332 2Five Questions About Protopic 28tacrolimus 29 Ointment 13332 3Five Questions About Protopic 28tacrolimus 29 Ointment 13332 4Synthetic biology opportunities and risks 53488 1Synthetic biology opportunities and risks 53488 2Synthetic biology opportunities and risks 53488 3
...ed to exploring ways to broaden the use of clean, ...y 1 at Stanford University. , Energy Crossroads, ...ms to reduce society,s dependence on fossil fuels,...ion: Sparking Global Change." , Cathy Zoi, chief ...ection, a nonprofit organization founded by former...
...gist Stephan B. Poulter demonstrates in THE MOTHER... YOUR LIFE (Prometheus Books, $18.95) that most of...ted by our mothers or its far-reaching impact on o... the foundation from which our emotional developme...ve through adulthood. No other relationship in ou...
...ollaborative effort, researchers from Boston Unive...at deletions or mutations within the TFAP2A gene (... distinctive clefting disorder Branchio-Oculo-Faci...erized by specific skin anomalies involving the ne...l facial appearance, and frequently cleft lip and ...
Other Biology News:How your mother's emotional legacy impacts your life 2
... SYBR Green, TaqMan, LNA spiked TaqMan, MethyLight...specific primers are designed by avoiding cross ho... search results. Primer efficiency is enhanced by ...by connecting to the Mfold server. Beacon Designer...
Goat Anti-Human IL-17D Polyclonal Antibody, Unconjugated from R&D Systems
...-ADP, FHS-LVF and CVD-Diffuse We've combined our ...lters to create the world's first notch filter wit...andpass. Each filter features an excellent transmi...e filters -- with interference coatings applied to...
Agar - ULTRAPURE from GE Healthcare, formerly Amersham Biosciences
Biology Products: